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ABSTRACT 
Urothelial carcinoma is a common malignant neoplasm that has a poor prognosis and a high 
frequency of recurrence and metastasis. Constant disease surveillance with periodic and long 
term cystoscopy examination is necessary for management of the disease. However, the 
monitoring and therapy regimen is expensive, incurring a massive burden to patients and the 
government. Therefore, the development of specific biomarkers for urothelial carcinoma at 
an early stage and recurrence detection becomes a priority. Homeobox genes are a family of 
genes that are involved in tumourigenesis. They might be potential prognostic markers for 
urothelial carcinoma. The study investigated the expression pattern of NANOG which is one 
of a homeobox gene in different stages and grades of urothelial carcinoma. NANOG 
expressions were also correlated with patient demographic factors and clinicopathological 
parameters. The expression of NANOG in 100 formalin-fixed paraffin-embedded urothelial 
carcinoma tissues was determined by immunohistochemistry. Immunohistochemistry showed 
positive expression of NANOG in all specimens with detection in the cytoplasm, nuclei and 
the nuclear membrane of the cancer cells. The immunohistochemical expression of NANOG 
increased across stages and grades of the tumour. The expression of NANOG was not 
significantly associated with demographic factors; gender (p = 0.376), race (p = 0.718) and 
age (p = 0.058) as well as with most of the clinicopathological parameters; pathological stage 
(p = 0.144), grade (p = 0.625), lymph node involvement (p = 0.174) and distant metastasis (p 
= 0.228). However, NANOG expression showed significant correlation with tumour invasion 
(p = 0.019). We concluded that NANOG might be a potential biomarker for early diagnosis 
of urothelial carcinoma of the bladder. 
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